RecruitingPhase 4NCT07114120

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

214 participants

Start Date

Jul 14, 2025

Study Type

INTERVENTIONAL

Conditions

COPD Bronchiectasis

Summary

The goal of this clinical trial is to learn if Bailing Capsules in combination Guben Kechuan Granules works to treat stable bronchiectasis in adults.It will also learn about the safety of Bailing Capsules in combination Guben Kechuan Granules The main questions it aims to answer are: Does Bailing Capsules in combination Guben Kechuan Granules lower the number of acute exacerbation in patients with stable bronchiectasis? The safety of the combination of Bailing Capsules and Guben Kechuan Granules ? Researchers will compare the combination of Bailing Capsules and Guben Kechuan Granules to standard Western medical treatment to see if them works to treat stable bronchiectasis. Participants will: Take Bailing Capsules orally (four capsules each time, three times a day) and Guben Kechuan Granules ( three times a day, 1 bag each time )on the basis of standard Western medical treatment or only standard Western medical treatment for 24 weeks Visit the clinic for checkups and tests on 4, 12, 24, 48 weeks Keep a diary of their symptoms

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether two traditional Chinese herbal medicines — Bailing Capsules and Guben Kechuan Granules — can help people with stable bronchiectasis, a chronic lung condition where the airways are permanently widened and prone to repeated infections. **You may be eligible if...** - You are 18–80 years old - You have a confirmed diagnosis of bronchiectasis - Your condition has been stable for the past 4 weeks (no acute flare-ups) - You have had at least two documented infections in the past year - Your breathing tests show reduced airflow (FEV1/FVC less than 70%) **You may NOT be eligible if...** - Your bronchiectasis is caused by cystic fibrosis or other specific conditions - You have other serious lung diseases like asthma, lung cancer, or active tuberculosis - You have serious heart, liver, kidney, or blood disorders - You are currently coughing up large amounts of blood Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.